Effects of avitinib on the pharmacokinetics of osimertinib in vitro and in vivo in rats

BACKGROUND: Avitinib is one type of the third‐generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of non‐small cell lung cancer (NSCLC) with EGFR mutations. The purpose of this study was to investigate the effect of avitinib on the pharmacokinetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qingjun, Jiang, Hui, Wang, Shuanghu, Dai, Dapeng, Chen, Feifei, Meng, Deru, Geng, Peiwu, Tong, Hongfeng, Zhou, Yunfang, Pan, Debiao, Zhou, Quan, Wang, Chunjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529555/
https://www.ncbi.nlm.nih.gov/pubmed/32812378
http://dx.doi.org/10.1111/1759-7714.13587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529555/
https://www.ncbi.nlm.nih.gov/pubmed/32812378
http://dx.doi.org/10.1111/1759-7714.13587

Ejemplares similares